Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 110 Carcinoma, Intraductal, Noninfiltrating 7 Breast Carcinoma In Situ 6 Neoplasms 4 Neoplasm Metastasis 3 Inflammatory Breast Neoplasms 3 Carcinoma, Ductal, Breast 3 Breast Neoplasms, Male 3 Infertility 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Breast Cancer Female 2 Sleep Wake Disorders 1 Quality of Life 1 Pulmonary Fibrosis 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Polycystic Ovary Syndrome 1 Paget's Disease, Mammary 1 Ovarian Neoplasms 1 Obesity 1 Neoplasm Recurrence, Local 1 Liver Neoplasms 1 Hot Flashes 1 Fatigue 1 Cardiotoxicity 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Subjects 1

Interventions

Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Density × Tamoxifen × Clear all

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

AstraZeneca

Phase 3 Completed

Bone Density

Data powered by HemOnc (CC BY 4.0) Colophon ⚡